217 related articles for article (PubMed ID: 24648916)
1. Potential combinatorial effects of recombinant atypical chemokine receptors in breast cancer cell invasion: A research perspective.
Chew AL; Tan WY; Khoo BY
Biomed Rep; 2013 Mar; 1(2):185-192. PubMed ID: 24648916
[TBL] [Abstract][Full Text] [Related]
2. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
3. Expression of chemokine decoy receptors and their ligands at the porcine maternal-fetal interface.
Wessels JM; Linton NF; van den Heuvel MJ; Cnossen SA; Edwards AK; Croy BA; Tayade C
Immunol Cell Biol; 2011 Feb; 89(2):304-13. PubMed ID: 20680026
[TBL] [Abstract][Full Text] [Related]
4. Chemokine sequestration by atypical chemokine receptors.
Hansell CA; Simpson CV; Nibbs RJ
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1009-13. PubMed ID: 17073739
[TBL] [Abstract][Full Text] [Related]
5. Post-translational control of chemokines: a role for decoy receptors?
Comerford I; Nibbs RJ
Immunol Lett; 2005 Jan; 96(2):163-74. PubMed ID: 15585320
[TBL] [Abstract][Full Text] [Related]
6. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy.
Sjöberg E; Meyrath M; Chevigné A; Östman A; Augsten M; Szpakowska M
Adv Cancer Res; 2020; 145():99-138. PubMed ID: 32089166
[TBL] [Abstract][Full Text] [Related]
7. Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines.
Haraldsen G; Rot A
Eur J Immunol; 2006 Jul; 36(7):1659-61. PubMed ID: 16791884
[TBL] [Abstract][Full Text] [Related]
8. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
9. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
[TBL] [Abstract][Full Text] [Related]
10. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
11. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.
Locati M; Torre YM; Galliera E; Bonecchi R; Bodduluri H; Vago G; Vecchi A; Mantovani A
Cytokine Growth Factor Rev; 2005 Dec; 16(6):679-86. PubMed ID: 15996892
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.
Vinet J; van Zwam M; Dijkstra IM; Brouwer N; van Weering HR; Watts A; Meijer M; Fokkens MR; Kannan V; Verzijl D; Vischer HF; Smit MJ; Leurs R; Biber K; Boddeke HW
Br J Pharmacol; 2013 Mar; 168(6):1375-87. PubMed ID: 23121557
[TBL] [Abstract][Full Text] [Related]
13. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
14. CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.
Catusse J; Clark DJ; Gompels UA
J Inflamm (Lond); 2009 Jul; 6():22. PubMed ID: 19643012
[TBL] [Abstract][Full Text] [Related]
15. Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.
Takatsuka S; Sekiguchi A; Tokunaga M; Fujimoto A; Chiba J
J Pharmacol Toxicol Methods; 2011; 63(3):250-7. PubMed ID: 21184834
[TBL] [Abstract][Full Text] [Related]
16. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.
Wang J; Ou ZL; Hou YF; Luo JM; Shen ZZ; Ding J; Shao ZM
Oncogene; 2006 Nov; 25(54):7201-11. PubMed ID: 16785997
[TBL] [Abstract][Full Text] [Related]
18. Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.
Novitzky-Basso I; Rot A
Front Immunol; 2012; 3():266. PubMed ID: 22912641
[TBL] [Abstract][Full Text] [Related]
19. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
[TBL] [Abstract][Full Text] [Related]
20. The biochemistry and biology of the atypical chemokine receptors.
Graham GJ; Locati M; Mantovani A; Rot A; Thelen M
Immunol Lett; 2012 Jul; 145(1-2):30-8. PubMed ID: 22698181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
